Outcomes in patients with classical Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: Real world analysis from 14 US academic centers Meeting Abstract
| Authors: | Voorhees, T.; McLaughlin, E.; Torka, P.; Florindez, J. A.; Moyo, T. K.; Reves, H.; Sumransub, N.; Deshpande, S.; Rose, A.; Duarte, C.; Faisal, M. S.; Hamid, S.; Subbiah, S.; Ayyappan, S. R.; Shea, L. K.; Cortese, M. J.; Patel, K.; Major, A.; Saeed, H.; Svoboda, J.; Desai, S. H.; Geethakumari, P. R.; Grover, N. S.; Epperla, N. |
| Abstract Title: | Outcomes in patients with classical Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: Real world analysis from 14 US academic centers |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3061 |
| Language: | English |
| ACCESSION: | WOS:001159740302170 |
| DOI: | 10.1182/blood-2023-181056 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
